Media, Video 22 Sep 2020 Video | Proactive Investors Interview – September 2020 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an… Orthocell
Media 29 Nov 2019 Orthocell – The Next Big Winner In The Regenerative Sector Greg Tolpigin has published positive commentary about the future of Orthocell, and the potential for our CelGroâ„¢ product in this… Orthocell
Media 12 Nov 2019 Orthocell receives patent for breakthrough CelGro ‘collagen rope’ to treat ACL injuries Small Caps has reported on Orthocell's recent patent announcement for our breakthrough CelGro collagen rope device to enhance the surgical repair… Orthocell
Media 09 Oct 2019 Orthocell on course to revolutionise nerve regeneration after positive interim clinical results Orthocell has been featured in Small Caps following positive interim clinical results for CelGroâ„¢, a collagen medical device that facilitates… Orthocell
Media 09 Oct 2019 Orthocell shares boosted by nerve repair trial success Journalist Sarah Jane Tasker, from The Australian, discusses the positive results from Orthocell's clinical trial of nerve repair product, CelGroâ„¢,… Orthocell
Media 04 Sep 2019 Orthocell reports high success rate from CelGro surgical trial on patients with rotator cuff injuries Small Caps has reported on the follow-up results from our CelGroâ„¢ tendon regeneration clinical trial, confirming all patients with rotator… Orthocell
Media 25 Jul 2019 Orthocell’s latest pre-clinical study underlines CelGroâ„¢ performance in nerve repair Orthocell's pre-clinical results for the use of CelGroâ„¢ in enhancing the repair of severed peripheral nerves have been featured in… Orthocell
Media 19 Jun 2019 Orthocell’s CelGro bone regeneration device accelerates dental implant treatment timeframes, cuts costs Small Caps has featured the outcomes of Orthocell's single-stage dental implant study, evaluating treatment with our CelGro™ collagen membrane. Orthocell
Media 28 May 2019 Bell Potter launches placement for Orthocell Orthcell's planned equity raise has been featured in AFR's Street Talk. Orthocell
Media 14 May 2019 Orthocell shares spike 350% following interim results of Celgro nerve regeneration study Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients… Orthocell
